Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

CUSIP: 78667J108

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Shares outstanding
62,650,155
Total 13F shares
58,089,604
Share change
+5,314,977
Total reported value
$10,632,783,890
Put/Call ratio
158%
Price per share
$183.09
Number of holders
265
Value change
+$989,879,978
Number of buys
139
Number of sells
112

Quarterly Holders Quick Answers

What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q2 2019

As of 30 Jun 2019, Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by 265 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,089,604 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, VANGUARD GROUP INC, Capital International Investors, JENNISON ASSOCIATES LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., JANUS HENDERSON GROUP PLC, and Bellevue Group AG. This page lists 265 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.